A team of pediatricians at the Medical University of South
Read moreUsing novel MIS-C therapy, team successfully treats two patients with multisystem inflammatory syndrome in children
U.S. FDA Approves Yescarta for Relapsed or Refractory Follicular Lymphoma After Two or More Lines of Systemic Therapy
SANTA MONICA, Calif.–(BUSINESS WIRE)–Mar. 5, 2021– Kite, a Gilead Company (Nasdaq: GILD),
Read moreGout drug help cuts need for oxygen therapy and hospital stay in COVID-19 patients
Colchicine, a cheap drug normally used to treat gout, helps
Read moreStudy examines attitudes toward long-acting injectable HIV therapy among women
A study led by Columbia University Mailman School of Public
Read morePfizer Doses First Participant in Phase 3 Study Evaluating anti-TFPI Investigational Therapy, Marstacimab, for People With Severe Hemophilia A and B With or Without Inhibitors
NEW YORK–(BUSINESS WIRE) November 23, 2020 — Pfizer Inc. (NYSE:
Read moreNew gene therapy developed for treating eye disease that leads to a progressive loss of vision
Scientists from Trinity College Dublin have developed a new gene
Read morePfizer and Sangamo Dose First Participant in Phase 3 Study Evaluating Hemophilia A Gene Therapy Treatment SB-525
NEW YORK & BRISBANE, Calif.–(BUSINESS WIRE) October 07, 2020 —
Read moreStudy reveals these lifestyle changes to reduce stress and blood pressure
A team of researchers has now explored the possibility of
Read moreA new cell and gene therapy approach to treat common bleeding disorder
In a new study from the Wake Forest Institute for
Read moreTriple inhaled therapy aids in moderate-to-very severe COPD
(HealthDay)—Triple therapy, including glucocorticoid at either of two dose levels,
Read more